Market Overview

Zogenix Shares Rally as FDA Redschedules Hydrocodone Drugs Panel

Share:
Related ZGNX
Zogenix Received FDA Approval, Now What?
What Investors Are Watching Ahead of Zogenix's FDA Approval Decision

Shares of Zogenix (NASDAQ: ZGNX) rallied more than 10 percent on Tuesday following news the FDA rescheduled an advisory panel for hydrocodone drugs to January 24th-25th.

View pdf.

Posted-In: News FDA Movers

 

Related Articles (ZGNX)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga PRO content